What AbbVie’s Bretisilocin Acquisition Means for Its Share Price in 2025
If you are staring at AbbVie’s share price and wondering whether now is the right time to buy or hold, you are definitely not alone. AbbVie has been making plenty of moves lately both on the market and in the news, with something for almost every kind of investor to consider. Over the past year, the stock has put up a strong 23.6% gain, and if you zoom out to five years, AbbVie has more than tripled, rising 230.5%. Even year-to-date, it is up an impressive 27.7%. That kind of return is hard to ignore, especially when much of the S&P 500 has been much bumpier.
Of course, these results have not come in a perfectly straight line. Over the last month, AbbVie gained 4.9% but dipped 1.6% in just the past week. These short-term swings partly…
